发明申请
- 专利标题： NOVEL INHIBITOR OF ANGIOGENESIS
- 专利标题（中）： 新生血管生成抑制剂
-
申请号： US13142541申请日： 2008-07-04
-
公开(公告)号： US20120021974A1公开(公告)日： 2012-01-26
- 发明人: Taavi Pall , Wally Anderson , Lagle Kasak , Anne Pink , Priit Kogerman , Aire Allikas , Andres Valkna
- 申请人： Taavi Pall , Wally Anderson , Lagle Kasak , Anne Pink , Priit Kogerman , Aire Allikas , Andres Valkna
- 申请人地址： EE Tallinn
- 专利权人： IBCC HOLDING AS
- 当前专利权人： IBCC HOLDING AS
- 当前专利权人地址： EE Tallinn
- 优先权： US60949518 20070713
- 国际申请： PCT/EP2008/058697 WO 20080704
- 主分类号： A61K38/17
- IPC分类号： A61K38/17 ; A61P35/00 ; A61P9/10 ; A61P29/00 ; A61P17/06 ; A61P27/02 ; C07K14/47 ; A61P35/04
摘要：
The invention relates to a method of treatment for states related to inhibition of angiogenesis and endothelial cell proliferation comprising administering an effective amount of vimentin or its derivatives or its fragments, to a subject in need thereof. Further, the invention relates to a pharmaceutical composition and a medicament comprising vimentin, as well as the use of vimentin in the manufacture of a medicament. Hereby, angiogenesis and endothelial cell proliferation can be controlled, and therapeutic treatment for related states is provided.
公开/授权文献
信息查询
IPC分类:
